Frank E. Thomas - 13 May 2025 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Reporting relationship: Director
Issuer ticker: LRMR
Reported as of: 13 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2025, 16:32:51 UTC
Prior SEC filing: 31 May 2024
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Johansson, Attorney-in-fact

Key filing fact

Frank E. Thomas filed Form 4 for Larimar Therapeutics, Inc. (LRMR) on 14 May 2025.

Key facts

This page summarizes Frank E. Thomas's Form 4 filing for Larimar Therapeutics, Inc. (LRMR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 May 2025, 16:32.

Change

Previous filing in this sequence was filed on 31 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001242616 Primary reporting owner

THOMAS FRANK E

Relationship: Director
Address: C/O LARIMAR THERAPEUTICS, INC., THREE BALA PLAZA EAST, SUITE 506, BALA CYNWYD
Signature: /s/ Jennifer Johansson, Attorney-in-fact
Signature date: 14 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LRMR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +19,000
Change %
Price: $0.000000
Shares after: 19,000
Date: 13 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,000
Exercise price: $1.88
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.